While much of the world tries to forget Covid-19 ever happened, Iwasaki’s research into — and communication about — the coronavirus and long Covid has amassed her more than 200,000 Twitter followers and made her an indispensable source for journalists covering the still-mysterious illness that follows an initial Covid infection. Among her 2022 publications were a preprint study identifying immunological differences in people with long Covid, a Nature study on the neurobiology of the chronic condition, and a paper in Science about her promising work into a Covid vaccine that would not be a shot, but a nasal spray.
More in Academia
Academia
Alberto Ascherio
Professor of epidemiology and nutrition, Harvard T.H. Chan School of Public Health
Academia
Euan Ashley
Professor of medicine and genomics, Stanford School of Medicine
Academia
Carolyn Bertozzi
Professor of chemistry, Stanford University
Academia
Kirsten Bibbins-Domingo
Editor-in-chief, JAMA
Academia
Maria Elena Bottazzi
Co-director, Texas Children’s Hospital Center for Vaccine Development
Academia
Daniel Dawes
Executive director, Global Health Equity Institute, Meharry Medical College
Academia
Amy Finkelstein
Professor of economics, MIT
Academia
Rachel Hardeman
Director, Center for Antiracism Research for Health Equity, UMN
Academia
Jonathan Jackson
Executive director, CARE Research Center at Mass. General
Academia
Keaweʻaimoku Kaholokula
Chair, Native Hawaiian Health, University of Hawai‘i at Mānoa
Academia
Marc Lipsitch
Director of science, CDC Center for Forecasting and Outbreak Analytics
Academia
Valerie Montgomery Rice
President & CEO, Morehouse School of Medicine
Academia
Roderic Pettigrew
Dean, Intercollegiate School of Engineering Medicine, Texas A&M
Academia
Anne Rimoin
Professor of Epidemiology, UCLA Fielding School of Public Health
Academia
Emily Wang
Professor, Yale School of Medicine